Vitamin D Resists Cyclophosphamide-Induced Genomic and DNA Damage in CHL Cells In Vitro and in Mice In Vivo

References

• Schuste I: Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta 1814, 186–199, 2011.
   PubMed Web of Science ®Google Scholar
• Chen L, Yang R, Qiao W, Yuan X, and Wang S: 1,25-Dihydroxy vitamin D prevents tumorigenesis by inhibiting oxidative stress and inducing tumor cellular senescence in mice. Int J Cancer 143, 368–382, 2018.
   PubMed Web of Science ®Google Scholar
• Tommie JL, Pinney SM, and Nommsen-Rivers LA : Serum vitamin D status and breast cancer risk by receptor status: a systematic review. Nutr Cancer 21, 1–17, 2018.
   Google Scholar
• Manar A, and Foad A: Vitamin D and breast cancer: latest evidence and future steps. Breast Cancer 11, 1–8, 2017.
   Web of Science ®Google Scholar
• Morales-Oyarvide V, Meyerhardt JA, and Ng K: Vitamin D and physical activity in patients with colorectal cancer: epidemiological evidence and therapeutic implications. Cancer J 22, 223–231, 2016.
   PubMed Web of Science ®Google Scholar
• Seyedalipour F, Mansouri A, Vaezi M, Gholami K, Heidari K, et al.: High prevalence of vitamin D deficiency in newly diagnosed acute myeloid leukemia patients and its adverse outcome. Int J Hematol Oncol Stem Cell Res 11, 209–216, 2017.
   PubMedGoogle Scholar
• Ma K, Xu W, Wang C, Li B, Su K, et al.: Vitamin D deficiency is associated with a poor prognosis in advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy. Cancer Biomark 18, 297–303, 2017.
   PubMed Web of Science ®Google Scholar
• Ismail A, El-Awady R, Mohamed G, Hussein M, and Ramadan SS : Prognostic significance of serum vitamin D levels in Egyptian females with breast cancer. Asian Pac J Cancer Prev 19, 571–576, 2018.
   PubMedGoogle Scholar
• Fuchs MA, Yuan C, Sato K, Niedzwiecki D, Ye X, et al.: Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance). Ann Oncol 28, 1359–1367, 2017.
   PubMed Web of Science ®Google Scholar
• Hadji P, Kauka A, Ziller M, Birkholz K, Baier M, et al.: Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study. Breast Cancer Res Treat 144, 343–351, 2014.
   PubMed Web of Science ®Google Scholar
• Charehbili A, Hamdy NA, Smit VT, Kessels L, van Bochove A, et al.: Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: data from the NEOZOTAC trial (BOOG 10-01). Breast 25, 69–74, 2016.
   PubMed Web of Science ®Google Scholar
• Lawrence JA, Akman SA, Melin SA, Case LD, and Schwartz GG: Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: a feasibility trial. Cancer Biol Ther 14, 476–480, 2013.
   PubMed Web of Science ®Google Scholar
• Rouphael C, Kamal A, Sanaka MR, and Thota PN: Vitamin D in esophageal cancer: is there a role for chemoprevention? World J Gastrointest Oncol 10, 23–30, 2018.
   PubMed Web of Science ®Google Scholar
• Hellström E, Robèrt KH, Samuelsson J, Lindemalm C, Grimfors G, et al.: Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a iving chemotherapy for metastatic breast cancer: a feasibility trial. Cancer Biol Ther 14, 476–480, 1990.
   Google Scholar
• Hoffer LJ, Robitaille L, Swinton N, Agulnik J, Cohen V, et al.: Appropriate vitamin D loading regimen for patients with advanced lung cancer. Nutr J 15, 84, 2016.
   PubMed Web of Science ®Google Scholar
• Clark AS, Chen J, Kapoor S, Friedman C, Mies C, et al.: Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657). Cancer Med 3, 693–701, 2014.
   PubMed Web of Science ®Google Scholar
• Peng X, Vaishnav A, Murillo G, Alimirah F, Torres KE, et al.: Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells. J Cell Biochem 110, 1324–1333, 2010.
   PubMed Web of Science ®Google Scholar
• Song EJ, Gordon-Thomson C, Cole L, Stern H, Halliday GM, et al.: 1α,25-Dihydroxyvitamin D3 reduces several types of UV-induced DNA damage and contributes to photoprotection. J Steroid Biochem Mol Biol 136, 131–138, 2013.
   PubMed Web of Science ®Google Scholar
• Cohen JL, and Jao JY: Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat. J Pharmacol Exp Ther 174, 206–210, 1996.
   Google Scholar
• Biswas S, Talukder G, and Sharma A : Chromosome damage induced by selenium salts in human peripheral lymphocytes. Toxicol In Vitro 14, 405–408, 2000.
   PubMed Web of Science ®Google Scholar
• Olive PL, and Banath JP: The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 1, 23–29, 2006.
   PubMed Web of Science ®Google Scholar
• Henry HL, and Norman AW: Vitamin D: metabolism and biological actions. Annu Rev Nutr 4, 493–520, 1984.
   PubMed Web of Science ®Google Scholar
• Morre FR, Urda GA, Krishna G, and Theiss JC: An in vivo/in vitro method for assessing micronucleus and chromosome aberration induction in rat bone marrow and spleen 1. Studies with cyclophosphamide. Mut Res 335, 191–199, 1995.
   PubMedGoogle Scholar
• Murata M, Suzuki T, Midorikawa K, Oikawa S, and Kawanishi S: Oxidative DNA damage induced by a hydroperoxide derivative of cyclophosphamide. Free Radic Biol Med 37, 793–802, 2004.
   PubMed Web of Science ®Google Scholar
• Saha BK, Bishayee A, Kanjilal NB, and Chatterjee M : 1Alpha,25-dihydroxyvitamin D3 inhibits hepatic chromosomal aberrations, DNA strand breaks and specific DNA adducts during rat hepatocarcinogenesis . Cell Mol Life Sci 58, 1141–1149, 2001.
   PubMed Web of Science ®Google Scholar
• Sarkar A, Saha BK, Basak R, Mukhopadhyay I, Karmakar R, and Chatterjee M: Anticlastogenic potential of 1a,25-dihydroxyvitamin D3 in murine lymphoma. Cancer Lett 150, 1–13, 2000.
   PubMed Web of Science ®Google Scholar
• Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, and Mangelsdorf DJ: Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126, 789–799, 2006.
   PubMed Web of Science ®Google Scholar
• Natarajan AT: Chromosome aberrations: past, present and future. Mutat Res 504, 3–16, 2002.
   PubMed Web of Science ®Google Scholar
• Halicka HD, Zhao H, Li J, Traganos F, Studzinski GP, and Darzynkiewicz Z: Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3. Aging (Albany NY) 4, 270–278, 2012.
   PubMedGoogle Scholar
• Li S, Armstrong CM, Bertin N, Ge H, Milstein S, et al.: A map of the interactome network of the metazoan C. elegans. Science 303, 540–543, 2004.
   PubMed Web of Science ®Google Scholar
• O’Neil N, and Rose A: DNA repair. WormBook [Internet]. The C. Elegans Research Community. http://www.wormbook.org. Accessed 11 Jun 2017.
   Google Scholar
• Jakob B, Splinter J, Conrad S, Voss KO, Zink D, et al.: DNA double-strand breaks in heterochromatin elicit fast repair protein recruitment, histone H2AX phosphorylation and relocation to euchromatin. Nucleic Acids Res 39, 6489–6499, 2011.
   PubMed Web of Science ®Google Scholar